Howard Hughes Medical Institute (HHMI) researchers at Stanford University have found that they can increase bone mass in mice by tweaking the shape of a regulatory protein. That protein, NFATc1, or other proteins that regulate its activity might make good targets for drugs to treat osteoporosis.
